Hypertensive heart disease: risk factors, complications and mechanisms

SK Masenga, A Kirabo - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Hypertensive heart disease constitutes functional and structural dysfunction and
pathogenesis occurring primarily in the left ventricle, the left atrium and the coronary arteries …

Inflammatory and molecular pathways in heart failure—ischemia, HFpEF and transthyretin cardiac amyloidosis

D Michels da Silva, H Langer, T Graf - International journal of molecular …, 2019 - mdpi.com
Elevated pro-inflammatory biomarkers and cytokines are associated with morbidity and
mortality in heart failure (HF). Preclinical and clinical studies have shown multiple …

Cardioprotection and lifespan extension by the natural polyamine spermidine

T Eisenberg, M Abdellatif, S Schroeder, U Primessnig… - Nature medicine, 2016 - nature.com
Aging is associated with an increased risk of cardiovascular disease and death. Here we
show that oral supplementation of the natural polyamine spermidine extends the lifespan of …

Heart failure with preserved ejection fraction—a concise review

DM Adamczak, MT Oduah, T Kiebalo… - Current cardiology …, 2020 - Springer
Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) is a
relatively new disease entity used in medical terminology; however, both the number of …

Lipotoxicity: a driver of heart failure with preserved ejection fraction?

J Leggat, G Bidault, A Vidal-Puig - Clinical Science, 2021 - portlandpress.com
Heart failure with preserved ejection fraction (HFpEF) is a growing public health concern,
with rising incidence alongside high morbidity and mortality. However, the pathophysiology …

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction

P Garg, H Assadi, R Jones, WB Chan, P Metherall… - Scientific Reports, 2021 - nature.com
Cardiac magnetic resonance (CMR) is emerging as an important tool in the assessment of
heart failure with preserved ejection fraction (HFpEF). This study sought to investigate the …

Heart failure with preserved ejection fraction: present status and future directions

S Yoon, GH Eom - Experimental & molecular medicine, 2019 - nature.com
The clinical importance of heart failure with preserved ejection fraction (HFpEF) has recently
become apparent. HFpEF refers to heart failure (HF) symptoms with normal or near-normal …

Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview

X Li, C Sun, J Zhang, L Hu, Z Yu, X Zhang… - Frontiers in …, 2023 - frontiersin.org
Background and ethnopharmacological relevance: The morbidity and mortality of
cardiovascular diseases (CVDs) are among the highest of all diseases, necessitating the …

Uraemic cardiomyopathy: a review of current literature

K Garikapati, D Goh, S Khanna… - Clinical Medicine …, 2021 - journals.sagepub.com
Uraemic Cardiomyopathy (UC) is recognised as an intricate and multifactorial disease which
portends a significant burden in patients with End-Stage Renal Disease (ESRD). The …

Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy

ÅT Røe, JM Aronsen, K Skårdal… - Cardiovascular …, 2017 - academic.oup.com
Aims Concentric hypertrophy following pressure-overload is linked to preserved systolic
function but impaired diastolic function, and is an important substrate for heart failure with …